8-K: GoHealth Reports Strong Q4 and Fiscal Year 2024 Results, Fueled by Successful Annual Enrollment Period

GoHealth, Inc. announced strong financial results for Q4 and fiscal year 2024, driven by a successful Annual Enrollment Period, with significant growth in revenue, submissions, and adjusted EBITDA.

Summary

• GoHealth, Inc. reported its financial results for the three and twelve months ended December 31, 2024.
• Net revenues for Q4 2024 reached $389.1 million, a 41% increase year-over-year.
• Submissions for Q4 2024 grew to 481,445, a 67% increase year-over-year.
• The company achieved a net income of $58.0 million in Q4 2024, a $60.3 million improvement compared to the prior year period.
• Adjusted EBITDA for Q4 2024 surged to $117.8 million, a 107% increase year-over-year.
• Direct Operating Cost per Submission improved by 27% to $501 in Q4 2024.
• Full-year 2024 net revenues reached $798.9 million, a 9% increase year-over-year.
• Full-year 2024 submissions were 1,016,182, a 23% increase year-over-year.
• The company reported a net loss of $7.3 million for the full year 2024, an improvement of $144.0 million compared to the prior year.
• Adjusted EBITDA for the full year 2024 was $120.3 million, a 60% increase year-over-year.
• GoHealth successfully refinanced its credit facility with a new five-year term and lender group.
• The company supported nearly 3 million Medicare consumers in assessing benefit options in 2024.
• GoHealth implemented the PlanFit Save initiative and began receiving health plan compensation for membership retention.
• GoHealth remained a top partner to health plans based on submission volume.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, significant improvements in key metrics, and optimistic management commentary. The successful integration of e-TeleQuote and strategic initiatives contribute to the positive sentiment.

Positives

• Significant revenue growth in both Q4 and full-year 2024.
• Substantial increase in submissions, indicating strong customer acquisition.
• Significant improvement in net income, turning a loss into a profit in Q4.
• Strong growth in Adjusted EBITDA, reflecting improved profitability.
• Improved operating efficiency, as demonstrated by the decrease in Direct Operating Cost per Submission.
• Successful refinancing of the credit facility, providing financial stability.
• Successful onboarding and optimization of e-TeleQuote.
• Expansion of health plan partnerships.
• Continued investment in artificial intelligence and advanced analytics.

Negatives

• The company still reported a net loss of $7.3 million for the full year 2024, although it represents a significant improvement.
• Sales per Submission decreased to $804 in Q4 2024 from $957 in Q4 2023.
• Sales per Submission decreased to $781 for the full year 2024 from $866 for the full year 2023.

Risks

• The forward-looking statements are subject to risks, assumptions, and uncertainties that are difficult to predict.
• Actual results may differ materially from the results expressed or implied by the forward-looking statements.
• The company's future performance is subject to factors described in the company's filings with the Securities and Exchange Commission.

Future Outlook

The company is optimistic that the favorable market dynamics experienced in 2024 will persist through at least the first three quarters of 2025, with cautious optimism for similar favorable dynamics for the fourth quarter.

Management Comments

• Vijay Kotte, CEO of GoHealth, stated that the company's strong 2024 performance highlights its market-leading, technology-driven approach in the digital Medicare marketplace.
• Vijay Kotte noted that the company was pleased by the velocity of its efficiency improvements and the immediate impact of its technology initiatives on profitability.
• Brendan Shanahan, CFO of GoHealth, stated that the 2024 financial results demonstrate GoHealth's capacity to achieve exceptional performance through disciplined execution and strategic investment.
• Brendan Shanahan noted that the substantial year-over-year growth in net income and Adjusted EBITDA, coupled with significant gains in operating efficiency, reinforces the strength of the company's strategy.

Industry Context

GoHealth operates in the competitive health insurance marketplace, particularly focusing on Medicare plans. The company's success is tied to its ability to efficiently acquire customers and retain them, while managing operating costs. The integration of e-TeleQuote appears to be a strategic move to enhance growth and efficiency.

Comparison to Industry Standards

• GoHealth's Direct Operating Cost per Submission of $501 is described as industry-leading, suggesting a competitive advantage in customer acquisition efficiency.
• Without specific competitor data, it's difficult to fully assess GoHealth's performance against industry benchmarks, but the reported growth rates and efficiency improvements indicate a positive trend.
• Companies like SelectQuote and eHealth, Inc. are comparable in the health insurance marketplace, and comparing their growth rates, profitability, and customer acquisition costs would provide a more comprehensive industry comparison.

Stakeholder Impact

• Shareholders: Positive results likely to be well-received, potentially increasing share value.
• Employees: Improved financial performance could lead to increased job security and potential bonuses.
• Customers: Continued investment in technology and consumer experience could lead to better service.
• Health Plan Partners: GoHealth remaining a top partner based on submission volume strengthens relationships.
• Creditors: Successful refinancing of the credit facility improves the company's financial stability.

Next Steps

• The company will host a conference call on February 27, 2025, to discuss the financial results.
• GoHealth will continue to focus on driving sustainable, profitable growth, enhancing the consumer experience, and reinforcing market leadership through continued innovation and operational excellence.
• The company will continue to invest in artificial intelligence and advanced analytics.

Key Dates